Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004583197 | SCV005062807 | pathogenic | Cohen syndrome | 2023-11-13 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 16-33 of the VPS13B gene. This variant would be expected to be in-frame, preserving the integrity of the reading frame. This variant has not been reported in the literature in individuals affected with VPS13B-related conditions. This variant disrupts a region of the VPS13B protein in which other variant(s) (Deletion (Exons 26-32)) have been determined to be pathogenic (PMID: 29634382). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |